Mark Golberg Email & Phone Number

Greater Boston

Early Stage StartUp. Advanced imaging technologies for nerve evaluation in major extremity trauma. Business strategy and leadership role supporting a team of renowned orthopedic surgeons and technologists.

Greater Boston Area

Health Care operations and research transformation and analytics -specializing in data warehousing, OMOP/OHDSI, tranSMART, i2b2/SHRINE, value based care and population health enablement. Technology, organization strategy, and process improvement in service to biopharma, health plan, and academic medical center operations and research efforts.

Greater Boston Area

Innovation in Elder Care Services for improved outcomes

Greater Boston Area

Greater Boston Area

Population Health and Value Based Care Strategy, Operations, and Software Technology including personalized medicine and research analytics for Plans and Providers.

Greater Boston Area

Data warehousing and analytics for personalized medicine, value based care, and population health. Acquired by Deloitte in 2012.

Greater Boston Area

Founder of not-for-profit venture seeking to mine the combination of whole genome sequences and EMR phenotype for comparative effectiveness insights and new drug development opportunities. Secured cooperation and participation of Intermountain Health Care, Geisinger Health Systems, and Marshfield Clinic. Concept included life-time patient HIPAA permission model with IRB approval and provided for lifetime consumer access to pharmacogenomics alerts and PHR management. CGC was derived from, and based upon, my advisory role to the Harvard Children’s Hospital Gene Partnership Project (GPP) championed by Zac Kohane (Center for Biomedical Informatics) and Ken Mandl (Chair Biomedical Informatics and Population Health). GPP later became a client at Recombinant Data Corp.

Greater Boston Area

Led development, planning, FDA approval process, operations, finance, marketing, and commercialization strategy. ASP designs and manufactures compact Fluid Management Devices used primarily in the hospital Operating Room (OR) and Post- Anesthesia Care Unit (PACU). The initial "star" product of the company is the AirPurge™ System, the first and only stand-alone device available that automatically traps and disposes of AIR BUBBLES in intravenous (I.V.) lines. It is a compact, closed loop, stand-alone system that is easy to install and operate. AirPurge received FDA approval in 2014.

Greater Boston Area

Responsible for fund raising, product/market focus, strategic alliance/license development, operating plan development and day-to-day execution at this early stage biotech company. The Company had 12 employees, had more than 8 protein mimetic, therapeutic compounds in pre-clinical development, and was funded via angels and private equity. Raised angel capital and initiated and secured company’s first licensing offers. THR-184, a peptide therapeutic for acute kidney injury, entered Phase 2 clinical trials in the US and Canada 2014.

South County, Ri

Founder, designer, finance, and developer of this innovative waterfront community on Salt Pond in the Narragansett, RI area featuring innovative land use, conservation methods, and shingle-style architectural designs. 40 acres of home sites with a private marina, one cove, two islands, and a 40 acre waterfront park with hiking trails and kayak launching on Salt Pond with access to Block Island Sound.

Greater Boston Area

Top non-physician responsible for turnaround operations / strategy of this heavily venture backed but struggling physician practice management company’s New England Region. Day to day operational leadership and policy responsibility for the $20 million New England region including multi-site and multi-specialty practices ranging in size from 2-50 MDs. Turnaround achievements include the development of shared lab, imaging, billing, disease management, demand management, Medicare Total Risk Cap management, and hospitalist / call center services for all practices. In one year achieved double digit growth of revenue and profits on a same store basis. Major architect and corporate role in proposed re-start of company’s business concept and value proposition, equity restructuring, physician deals/incentives, and information systems strategy. Company liquidated in 1998 after major reversal in capital market valuations of PPM companies (e.g PhyCor).

Greater Boston Area

Venture backed, re-start / turnaround of this $35 million temporary staffing company (physician, RN, and allied health professions). Led a massive and complete restructuring of the company’s operations. Achieved a doubling of revenue and a quadrupling of profitability, and a 50+% improvement in productivity in two years. These actions increased company value and yielded a 25X return to investors upon its recap sale for $100+ million to Morgan Stanley Ventures. Merger IPO with Cross Country Staffing in 1999.

Greater New York City Area

Director and engagement manager to top management of leading US hospitals, clinics, and health care companies. Re-invented the firm's operations restructuring model by introducing intensive and widespread, client/hospital idea brainstorming sessions and intensive client training in operations engineering tools.Clinic and physician practice market sector development responsibilities. Extensive experience in cost and competitive strategy; world class expert in operations restructuring, redesign, clinical quality improvement, and turnarounds for major hospital systems and clinics -(pioneering innovations; reduction of controllable costs of 7-18% in all projects). Clients included: UCLA, SUNY-Stonybrook, HealthTrust, Inc., and The Mayo Clinic. Also, strategic planning and market opportunity analysis for major long term care companies. Extensive sales and product development record including customer driven incentive programs for front line staff, client operations engineering training (LEAN), and a proprietary database of ambulatory care and physician clinical productivity. APM later acquired by CSC.

Greater Boston Area

Consultant to top management of major industrial and health care companies in engagements addressing cost and competitive strategy for a major beverage can manufacturer, industrial marketing strategy and implementation for an industrial valve manufacturer, customer retention strategy for service companies, and M&A / alliance strategy for two major medical products companies.

Greater Boston Area

Consultant to top management of major consumer product and health care companies. Specific functional casework included acquisition and value creation strategy in the consumer products industry, value improvement and marketing strategy in the long term care industry: sales, market opportunity, and distribution strategy in the pharmaceutical, biotechnology, and medical products industries, and general hospital strategy. Additional experience in new product planning and introductions.

Greater Chicago Area

Founder and business concept developer of this innovative start-up including creator of “HEALTHTEX”, the “first of its kind”, on line consumer health/EMR storage website product distributed over the CompuServe Network. HRCA sought the holy grail of provider, plan, and consumer health engagement and delivered a provider sponsored plan with incentives for consumer price/quality discrimination, a website (HEALTHTEX) where consumers could find provider comparative price and quality data to discriminate on, and high performing hospitals and clinics. Assisted in growing the company to over $100MM in revenues in three years. Developed several of its core products including HEALTHTEX with its comparative data, its consumer EHR, its consumer PDR reference, its preventive medicine educational content and HRAs (health hazard appraisal tests); as well as, its innovative, incentive based, medical IRA type health insurance product, and assisted in the development of its chain of 15+ hospitals. NASDAQ IPO – 1984 and merged with Republic Health Corp. in 1985.

Washington D.C. Metro Area

Chief of staff to a small organization purposely formed to assist in the formulation of national health care policy by influencing the Reagan administration’s cabinet selections. Key members included Michael DeBakey M.D. and the leadership of Merck, Pfizer, Bell Labs etc…. Organized the first privately sponsored Senate hearings in U.S. history. Topic: Health Promotion and Disease Prevention. Wrote the national health policy white paper for a top candidate for Secretary of Health/Surgeon General based on my research and writings for Jeff Goldsmith’s book “Can Hospitals Survive?: The New Competitive Health Care Market”. HRCA Corp. was born out of these writings and relationships.

Mba, Strategy, Marketing, & New Product Lab

Bachelor'S Degree, Medical Anthropology